Methods
The DCCSS LATER 2 study is a cross-sectional study within the
multi-center LATER cohort of 6,165 five-year survivors of childhood
cancer, who were initially diagnosed between 1963-2001. (Teepen et al.
submitted) in the seven pediatric oncology centers in the Netherlands
(Amsterdam University Medical Center (VU Medical Center and Academic
Medical Center), Leiden University Medical Center, Erasmus Medical
Center Rotterdam, University Medical Center Groningen, Radboudumc
Nijmegen and University Medical Center Utrecht). Since 2018, is
pediatric oncology care centralized in the new Princess Máxima Center.